Halil Kavgacı

805 total citations
55 papers, 623 citations indexed

About

Halil Kavgacı is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Halil Kavgacı has authored 55 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 12 papers in Molecular Biology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Halil Kavgacı's work include Gastric Cancer Management and Outcomes (5 papers), Cancer Diagnosis and Treatment (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Halil Kavgacı is often cited by papers focused on Gastric Cancer Management and Outcomes (5 papers), Cancer Diagnosis and Treatment (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Halil Kavgacı collaborates with scholars based in Türkiye, United States and Togo. Halil Kavgacı's co-authors include Feyyaz Özdemir, Fazıl Aydin, Melek Yavuz, Orhan Değer, Gamze Çan, Cihangir Erem, Ahmet Menteşe, Funda Öztuna, Aydın Yavuz and Faruk Aydın and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Biomedicine & Pharmacotherapy.

In The Last Decade

Halil Kavgacı

55 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Halil Kavgacı Türkiye 14 174 132 106 97 96 55 623
Ziad Salem Lebanon 17 236 1.4× 139 1.1× 106 1.0× 63 0.6× 70 0.7× 40 708
Shadi A. Esfahani United States 16 130 0.7× 106 0.8× 114 1.1× 160 1.6× 155 1.6× 60 666
Maria Laura Canale Italy 15 204 1.2× 175 1.3× 209 2.0× 116 1.2× 122 1.3× 77 895
Feyyaz Özdemir Türkiye 13 217 1.2× 118 0.9× 97 0.9× 33 0.3× 95 1.0× 76 587
Tetsuya Takahashi Japan 15 122 0.7× 204 1.5× 171 1.6× 107 1.1× 128 1.3× 58 873
Hacı Mehmet Türk Türkiye 14 265 1.5× 128 1.0× 227 2.1× 53 0.5× 163 1.7× 75 708
Huei‐Ting Tsai United States 16 120 0.7× 76 0.6× 216 2.0× 37 0.4× 83 0.9× 27 589
Edith Bigot‐Corbel France 15 85 0.5× 170 1.3× 56 0.5× 70 0.7× 87 0.9× 54 575
Johann Pidlich Austria 16 195 1.1× 127 1.0× 88 0.8× 106 1.1× 216 2.3× 29 1.0k
Baudouin Leclercq United States 12 92 0.5× 157 1.2× 146 1.4× 90 0.9× 107 1.1× 19 1.1k

Countries citing papers authored by Halil Kavgacı

Since Specialization
Citations

This map shows the geographic impact of Halil Kavgacı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Halil Kavgacı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Halil Kavgacı more than expected).

Fields of papers citing papers by Halil Kavgacı

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Halil Kavgacı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Halil Kavgacı. The network helps show where Halil Kavgacı may publish in the future.

Co-authorship network of co-authors of Halil Kavgacı

This figure shows the co-authorship network connecting the top 25 collaborators of Halil Kavgacı. A scholar is included among the top collaborators of Halil Kavgacı based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Halil Kavgacı. Halil Kavgacı is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kavgacı, Halil, et al.. (2023). A different yet traditional approach to neoadjuvant treatment of breast cancer: The combination of epirubicin and docetaxel. The Annals of Clinical and Analytical Medicine. 14(Suppl_01). S76–80. 1 indexed citations
2.
Doğan, Mutlu, Mehmet Artaç, Levent Korkmaz, et al.. (2021). The Relationship Between Plexin C1 Overexpression and Survival in Hepatocellular Carcinoma: a Turkish Oncology Group (TOG) Study. Journal of Gastrointestinal Cancer. 53(2). 356–362. 3 indexed citations
3.
Kavgacı, Halil, et al.. (2018). The effects of environmental and dietary factors on the development of gastric cancer.. PubMed. 19(4). 1076–82. 9 indexed citations
4.
Koçoğlu, Hakan, Halil Kavgacı, Meral Günaldı, et al.. (2018). The clinical importance of serum galectin-3 levels in breast cancer patients with and without metastasis. Journal of Cancer Research and Therapeutics. 14(10). 583–583. 13 indexed citations
5.
Menteşe, Ahmet, Ahmet Alver, Selim Demir, et al.. (2017). Detection of autoantibodies against carbonic anhydrase I and II in the plasma of patients with gastric cancer. Central European Journal of Immunology. 42(1). 73–77. 4 indexed citations
6.
Beyhun, Nazım Ercüment, et al.. (2016). Validity and Reliability of the Turkish Version of Needs Based Biopsychosocial Distress Instrument for Cancer Patients (CANDI). Iranian Red Crescent Medical Journal. 18(6). e27352–e27352. 3 indexed citations
7.
Erçelep, Özlem, İbrahim Vedat Bayoğlu, Halil Kavgacı, et al.. (2016). Retrospective multicenter evaluation of patients diagnosed with mucosal melanoma: a study of Anatolian Society of Medical Oncology. Tumor Biology. 37(9). 12033–12038. 8 indexed citations
8.
Kavgacı, Halil, Emine Canyılmaz, Asım Örem, et al.. (2015). The effect of adjuvant chemotherapy on plasma TAT and F 1+2 levels in patients with breast cancer. Biomedicine & Pharmacotherapy. 73. 19–23. 4 indexed citations
9.
Özdemir, Feyyaz, et al.. (2014). Clinicopathological Characteristics of Triple-negative Breast Cancers in the Northeast Region of Turkey. Balkan Medical Journal. 31(2). 126–131. 2 indexed citations
10.
Menteşe, Ahmet, Halil Kavgacı, Asım Örem, et al.. (2012). Increased ischemia-modified albumin levels in patients with gastric cancer. Neoplasma. 59(4). 393–397. 26 indexed citations
11.
12.
Koşucu, Polat, Celal Tekinbaş, Ahmet Sarı, et al.. (2009). Mediastinal lymph nodes: Assessment with diffusion‐weighted MR imaging. Journal of Magnetic Resonance Imaging. 30(2). 292–297. 63 indexed citations
13.
Özdemir, Feyyaz, et al.. (2005). Hodgkin’s Disease and Autoimmune Hemolytic Anemia: A Case Report. Medical Principles and Practice. 14(3). 205–207. 11 indexed citations
14.
Kavgacı, Halil, et al.. (2004). Carcinoma Erysipelatoides Resulting from Gastric Adenocarcinoma: An Unusual Clinical Presentation. Medical Principles and Practice. 14(1). 61–63. 8 indexed citations
15.
Özdemir, Feyyaz, Ercüment Ovalı, Yavuz Tekelioğlu, et al.. (2004). Effects of Dexamethasone, All-Trans Retinoic Acid, Vitamin D<sub>3</sub> and Interferon-α on FO Myeloma Cells. Chemotherapy. 50(4). 190–193. 11 indexed citations
16.
Özdemir, Feyyaz, Ercüment Ovalı, Fazıl Aydin, et al.. (2004). The in-vitro effects of medroxyprogesterone acetate on acidic pH induced apoptosis of periferal blood mononuclear cells.. PubMed. 23(1). 93–5. 3 indexed citations
17.
Kavgacı, Halil, et al.. (2002). Respiratory Distress Due to Endotracheal Aspergilloma in an Immunocompromised Lymphoma Patient: Case Report. Journal of Chemotherapy. 14(1). 92–94. 5 indexed citations
18.
Aydin, Fazıl, et al.. (2002). Correlation of Serum IL-2, IL-6 and IL-10 Levels With International Prognostic Index in Patients With Aggressive Non-Hodgkin’s Lymphoma. American Journal of Clinical Oncology. 25(6). 570–572. 32 indexed citations
19.
Erem, Cihangir, Halil Kavgacı, Caner Karahan, et al.. (2001). Prevalence of diabetes, obesity and hypertension in a Turkish population (Trabzon city). Diabetes Research and Clinical Practice. 54(3). 203–208. 39 indexed citations
20.
Kavgacı, Halil, et al.. (1999). Akut Böbrek Yetmezliğinde Prognoza Etkili Faktörler. Turkiye Klinikleri Tip Bilimleri Dergisi. 19(6). 358–361. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ziad Salem Breakdown of academic impact, for papers by Shadi A. Esfahani Breakdown of academic impact, for papers by Maria Laura Canale Breakdown of academic impact, for papers by Feyyaz Özdemir Breakdown of academic impact, for papers by Tetsuya Takahashi Breakdown of academic impact, for papers by Hacı Mehmet Türk Breakdown of academic impact, for papers by Huei‐Ting Tsai Breakdown of academic impact, for papers by Edith Bigot‐Corbel Breakdown of academic impact, for papers by Johann Pidlich Breakdown of academic impact, for papers by Baudouin Leclercq
Rankless by CCL
2026